Mike Bruno advises emerging growth companies through all stages of the corporate lifecycle, from formation and day to day governance to venture financings and liquidity events, including public offerings and mergers and acquisitions. Mike also represents venture capital investors in financing transactions. 

Download full bio 


  • Tomorrow Health Closes $60 Million Series B 

  • Finch Therapeutics – $128 Million IPO 

  • LAVA Therapeutics – $107 Million IPO 

  • Landos Biopharma – $100 Million IPO 

  • Lumicks Closes $93 Million Series D Financing  



    Science fiction novels

    Steelers football


  • Fordham University School of Law
    JD, magna cum laude, Order of the Coif, 2020

  • Boston University
    BS, Business Administration
    magna cum laude, 2014

Admissions & Credentials

New York